Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Vitale

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|July 19, 2019
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and MoreMassimo Vitale, Claudia Cantoni, Mariella Della Chiesa, et al.
Frontiers in Immunology|June 25, 2019
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical ExploitationDaniela Pende, Michela Falco, Massimo Vitale, et al.
Blood|May 17, 2003
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytesRenato Zambello, Michela Falco, Mariella Della Chiesa, et al.
JPRAS Open|December 24, 2025
Efficacy of high-intensity focused ultrasound for treating upper and lower eyelid saggingYousun Hwang, Jin-Hyun Kim, Han Earl Lee, et al.
Haematologica|April 23, 2010
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytesCristina Gattazzo, Antonella Teramo, Marta Miorin, et al.
Frontiers in Immunology|June 30, 2023
Murine models to study human NK cells in human solid tumorsMonica Parodi, Simonetta Astigiano, Paolo Carrega, et al.
Frontiers in Immunology|February 17, 2025
CD94-driven <i>in vitro</i> expansion of highly functional adaptive NKG2C<sup>+</sup> NKG2A<sup>-</sup> CD57<sup>+</sup> NK cells from CMV<sup>+</sup> healthy donorsChiara Giordano, Simona Carlomagno, Michela Falco, et al.
International Immunology|December 17, 2009
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissuesMariella Della Chiesa, Michela Falco, Silvia Parolini, et al.
Oncoimmunology|September 20, 2018
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptorSilvia Gaggero, Maurizio Bruschi, Andrea Petretto, et al.
Cancer Research|January 20, 2012
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activityGabriella Pietra, Claudia Manzini, Silvia Rivara, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|July 19, 2019
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and MoreMassimo Vitale, Claudia Cantoni, Mariella Della Chiesa, et al.
Frontiers in Immunology|June 25, 2019
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical ExploitationDaniela Pende, Michela Falco, Massimo Vitale, et al.
Blood|May 17, 2003
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytesRenato Zambello, Michela Falco, Mariella Della Chiesa, et al.
JPRAS Open|December 24, 2025
Efficacy of high-intensity focused ultrasound for treating upper and lower eyelid saggingYousun Hwang, Jin-Hyun Kim, Han Earl Lee, et al.
Haematologica|April 23, 2010
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytesCristina Gattazzo, Antonella Teramo, Marta Miorin, et al.
Frontiers in Immunology|June 30, 2023
Murine models to study human NK cells in human solid tumorsMonica Parodi, Simonetta Astigiano, Paolo Carrega, et al.
Frontiers in Immunology|February 17, 2025
CD94-driven <i>in vitro</i> expansion of highly functional adaptive NKG2C<sup>+</sup> NKG2A<sup>-</sup> CD57<sup>+</sup> NK cells from CMV<sup>+</sup> healthy donorsChiara Giordano, Simona Carlomagno, Michela Falco, et al.
International Immunology|December 17, 2009
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissuesMariella Della Chiesa, Michela Falco, Silvia Parolini, et al.
Oncoimmunology|September 20, 2018
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptorSilvia Gaggero, Maurizio Bruschi, Andrea Petretto, et al.
Cancer Research|January 20, 2012
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activityGabriella Pietra, Claudia Manzini, Silvia Rivara, et al.
Pageof 8